Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk

被引:33
作者
Bouchard, G
Johnson, D
Carver, T
Paigen, B
Carey, MC [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA
[2] Harvard Univ, Ctr Digest Dis, Boston, MA 02115 USA
[3] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
cholesterol saturation index; monogenic and polygenic obesity genes; carboxypeptidase E; leptin; leptin receptor; cholecystokinin;
D O I
10.1194/jlr.M200102-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The relationship between obesity and cholesterol cholelithiasis is not well understood at physiologic or genetic levels. To clarify whether obesity per se leads to increased prevalence of cholelithiasis, we examined cholesterol gallstone susceptibility in three polygenic (KK/H1J, NON/LtJ, NOD/LtJ) and five monogenic [carboxypeptidase E (Cpe(fat)), agouti yellow (A(gamma)), tubby (tub), leptin (Lep(ob)), leptin receptor (Lepr(db))] murine models of obesity during ingestion of a lithogenic diet containing dairy fat, cholesterol, and cholic acid. At 8 weeks on the diet, one strain of polygenic obese mice was resistant whereas the others revealed low or intermediate prevalence rates of cholelithiasis. Monogenic obese mice showed distinct patterns with either high or low gallstone prevalence rates depending upon the mutation. Dysfunction of the leptin axis, as evidenced by the Lepob and the Lepr(db) mutations, markedly reduced gallstone formation in a genetically susceptible background strain, indicating that in mice with this genetic background, physiologic leptin homeostasis is a requisite for cholesterol cholelithogenesis. In contrast, the Cpe(fat) mutation enhanced the prevalence of cholelithiasis markedly when compared with the background strain. Since CPE converts many pro-hormones to hormones, a deficiency of biologically active cholecystokinin is a likely contributor to enhanced susceptibility to cholelithiasis through compromising gallbladder contractility and small intestinal motility. Because some murine models of obesity increased, whereas others decreased cholesterol gallstone susceptibility, we establish that cholesterol cholelithiasis in mice is not simply a secondary consequence of obesity per se. Rather, specific genes and distinct pathophysiological pathways are responsible for the shared susceptibility to both of these common diseases. Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk.
引用
收藏
页码:1105 / 1113
页数:9
相关论文
共 60 条
[1]  
APSTEIN MD, 1994, OFFICE PRACTICE MED, P277
[2]   Factors associated with gallstone disease in the MICOL experience [J].
Attili, AF ;
Capocaccia, R ;
Carulli, N ;
Festi, D ;
Roda, E ;
Barbara, L ;
Capocaccia, L ;
Menotti, A ;
Okolicsanyi, L ;
Ricci, G ;
Lalloni, L ;
Mariotti, S ;
Sama, C ;
Scafato, E ;
Muntoni, S ;
Taroni, F ;
Morisi, G ;
Valente, F .
HEPATOLOGY, 1997, 26 (04) :809-818
[3]   Neuropeptides and obesity [J].
Beck, B .
NUTRITION, 2000, 16 (10) :916-923
[4]   Independent and additive effects of central POMC and leptin pathways on murine obesity [J].
Boston, BA ;
Blaydon, KM ;
Varnerin, J ;
Cone, RD .
SCIENCE, 1997, 278 (5343) :1641-1644
[5]   The human obesity gene map:: The 1999 update [J].
Chagnon, YC ;
Pérusse, L ;
Weisnagel, SJ ;
Rankinen, T ;
Bouchard, C .
OBESITY RESEARCH, 2000, 8 (01) :89-117
[6]   INFLUENCE OF GENETIC BACKGROUND ON EXPRESSION OF OBESE (OB) GENE IN MOUSE [J].
COLEMAN, DL ;
HUMMEL, KP .
DIABETOLOGIA, 1973, 9 (04) :287-293
[7]   FAT (FAT) AND TUBBY (TUB) - 2 AUTOSOMAL RECESSIVE MUTATIONS CAUSING OBESITY SYNDROMES IN THE MOUSE [J].
COLEMAN, DL ;
EICHER, EM .
JOURNAL OF HEREDITY, 1990, 81 (06) :424-427
[8]   BIOLOGICAL ACTIONS OF CHOLECYSTOKININ [J].
CRAWLEY, JN ;
CORWIN, RL .
PEPTIDES, 1994, 15 (04) :731-755
[9]   INFLUENCE OF SMALL BOWEL TRANSIT-TIME ON DIETARY-CHOLESTEROL ABSORPTION IN HUMAN-BEINGS [J].
DELEON, MP ;
IORI, R ;
BARBOLINI, G ;
POMPEI, G ;
ZANIOL, P ;
CARULLI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (02) :102-103
[10]  
DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1